Skip to content
Disclosery

Rhenman & Partners Asset Management AB

Follow

13F filer, CIK 1599882, Stockholm, Sweden

Rhenman & Partners Asset Management AB reported $791,015,290 across 90 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-13. Its ten largest share positions make up 32.88% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001213900-25-075249

Period
2025-06-30
Reported value
$791M
Holdings
90
Top 10 weight
32.88%
New
11
Sold out
15

Largest buys vs the previous quarter

SecurityShares changeApprox. value
DHRadded+79,500$15.7M
LLYadded+16,120$12.6M
EHCadded+99,000$12.1M
CAHnew+55,000$9.24M
NBIXadded+59,400$7.47M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BMYexited-325,000-$19.8M
OSCRreduced-710,651-$15.2M
PRCTreduced-258,000-$14.9M
UNHreduced-47,000-$14.7M
MCKreduced-19,500-$14.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001213900-25-075249, largest first. % of portfolio is the value over $791,015,290, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 47,500 shares; 2024Q4: 45,450 shares; 2025Q1: 41,750 shares; 2025Q2: 57,870 shares 57,870$45.1M5.7%+16,120Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 590,000 shares; 2024Q4: 444,000 shares; 2025Q1: 300,000 shares; 2025Q2: 296,000 shares 296,000$31.8M4.02%-4,000Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 47,750 shares; 2024Q4: 50,000 shares; 2025Q1: 66,750 shares; 2025Q2: 61,455 shares 61,455$27.4M3.46%-5,295Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 111,000 shares; 2024Q4: 36,531 shares; 2025Q1: 270,000 shares; 2025Q2: 235,000 shares 235,000$24.3M3.07%-35,000Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 63,000 shares; 2024Q4: 64,000 shares; 2025Q1: 51,500 shares; 2025Q2: 44,350 shares 44,350$24.1M3.05%-7,150Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 221,400 shares; 2024Q4: 197,700 shares; 2025Q1: 126,700 shares; 2025Q2: 136,429 shares 136,429$24M3.04%+9,729Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 83,302 shares; 2024Q4: 63,952 shares; 2025Q1: 41,952 shares; 2025Q2: 121,452 shares 121,452$24M3.03%+79,500Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 184,000 shares; 2024Q4: 267,500 shares; 2025Q1: 235,862 shares; 2025Q2: 295,362 shares 295,362$20.4M2.58%+59,500Timeline
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 30,117 shares; 2024Q4: 34,117 shares; 2025Q1: 47,217 shares; 2025Q2: 27,717 shares 27,717$20.3M2.57%-19,500Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 71,750 shares; 2024Q4: 100,317 shares; 2025Q1: 89,817 shares; 2025Q2: 149,217 shares 149,217$18.8M2.37%+59,400Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 366,500 shares; 2024Q4: 255,500 shares; 2025Q1: 233,500 shares; 2025Q2: 168,150 shares 168,150$18.6M2.36%-65,350Timeline
EXASEXACT SCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 465,000 shares; 2024Q4: 471,000 shares; 2025Q1: 440,000 shares; 2025Q2: 350,000 shares 350,000$18.6M2.35%-90,000Timeline
ALHCALIGNMENT HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,977,363 shares; 2024Q4: 1,761,192 shares; 2025Q1: 1,337,284 shares; 2025Q2: 1,287,284 shares 1,287,284$18M2.28%-50,000Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 129,513 shares; 2024Q4: 61,500 shares; 2025Q1: 185,500 shares; 2025Q2: 175,435 shares 175,435$17.7M2.23%-10,065Timeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50,500 shares; 2024Q4: 23,150 shares; 2025Q1: 48,950 shares; 2025Q2: 44,650 shares 44,650$17.4M2.2%-4,300Timeline
EHCENCOMPASS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 61,000 shares; 2024Q4: 56,000 shares; 2025Q1: 37,400 shares; 2025Q2: 136,400 shares 136,400$16.7M2.11%+99,000Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50,350 shares; 2024Q4: 17,000 shares; 2025Q1: 48,197 shares; 2025Q2: 51,197 shares 51,197$16.7M2.11%+3,000Timeline
MDTMEDTRONIC PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 368,000 shares; 2024Q4: 269,500 shares; 2025Q1: 255,000 shares; 2025Q2: 179,500 shares 179,500$15.6M1.98%-75,500Timeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 45,150 shares; 2024Q4: 53,750 shares; 2025Q1: 32,375 shares; 2025Q2: 49,375 shares 49,375$14.8M1.87%+17,000Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 39,000 shares; 2024Q4: 43,457 shares; 2025Q1: 31,750 shares; 2025Q2: 27,700 shares 27,700$14.5M1.84%-4,050Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,000 shares; 2024Q4: 57,000 shares; 2025Q1: 61,000 shares; 2025Q2: 46,000 shares 46,000$14.5M1.83%-15,000Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 87,000 shares; 2024Q4: not reported; 2025Q1: 155,000 shares; 2025Q2: 159,500 shares 159,500$13.9M1.76%+4,500Timeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 177,000 shares; 2024Q4: 124,150 shares; 2025Q1: 88,650 shares; 2025Q2: 69,375 shares 69,375$12.9M1.63%-19,275Timeline
ALGNALIGN TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 55,000 shares; 2024Q4: 41,900 shares; 2025Q1: 41,500 shares; 2025Q2: 66,500 shares 66,500$12.6M1.59%+25,000Timeline
RPRXROYALTY PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 613,500 shares; 2024Q4: 595,000 shares; 2025Q1: 411,000 shares; 2025Q2: 344,000 shares 344,000$12.4M1.57%-67,000Timeline
COOCOOPER COS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 228,000 shares; 2024Q4: 115,000 shares; 2025Q1: 236,000 shares; 2025Q2: 170,000 shares 170,000$12.1M1.53%-66,000Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 93,000 shares; 2024Q4: 145,500 shares; 2025Q1: 124,300 shares; 2025Q2: 109,030 shares 109,030$11.6M1.46%-15,270Timeline
HCAHCA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 76,229 shares; 2024Q4: 34,379 shares; 2025Q1: 16,778 shares; 2025Q2: 29,778 shares 29,778$11.4M1.44%+13,000Timeline
PRCTPROCEPT BIOROBOTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 445,000 shares; 2024Q4: 420,345 shares; 2025Q1: 448,000 shares; 2025Q2: 190,000 shares 190,000$10.9M1.38%-258,000Timeline
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 41,685 shares; 2024Q4: 78,385 shares; 2025Q1: 28,200 shares; 2025Q2: 32,000 shares 32,000$10.6M1.34%+3,800Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 92,500 shares; 2025Q2: 197,600 shares 197,600$10.5M1.33%+105,100Timeline
VERONA PHARMA PLCVERONA PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 70,000 shares; 2025Q2: 106,500 shares 106,500$10.1M1.27%+36,500
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 231,000 shares; 2024Q4: 123,410 shares; 2025Q1: 138,500 shares; 2025Q2: 57,500 shares 57,500$9.71M1.23%-81,000Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 72,700 shares; 2024Q4: 60,530 shares; 2025Q1: 77,430 shares; 2025Q2: 30,430 shares 30,430$9.49M1.2%-47,000Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 122,600 shares; 2024Q4: 122,600 shares; 2025Q1: 109,600 shares; 2025Q2: 90,800 shares 90,800$9.48M1.2%-18,800Timeline
CAHCARDINAL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 55,000 shares 55,000$9.24M1.17%newTimeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 364,500 shares; 2024Q4: 250,623 shares; 2025Q1: 265,000 shares; 2025Q2: 149,650 shares 149,650$8.23M1.04%-115,350Timeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 135,000 shares; 2024Q4: 128,000 shares; 2025Q1: 52,000 shares; 2025Q2: 58,500 shares 58,500$7.96M1.01%+6,500Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 195,000 shares; 2024Q4: 212,500 shares; 2025Q1: 81,000 shares; 2025Q2: 182,000 shares 182,000$7.19M0.91%+101,000Timeline
OSCROSCAR HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,371,147 shares; 2024Q4: 1,362,421 shares; 2025Q1: 1,022,743 shares; 2025Q2: 312,092 shares 312,092$6.69M0.85%-710,651Timeline
MOHMOLINA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 29,600 shares; 2024Q4: 34,200 shares; 2025Q1: 68,200 shares; 2025Q2: 22,200 shares 22,200$6.61M0.84%-46,000Timeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 79,500 shares; 2024Q4: 74,500 shares; 2025Q1: 74,500 shares; 2025Q2: 116,000 shares 116,000$6.1M0.77%+41,500
ALCALCON AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 68,000 shares 68,000$5.99M0.76%newTimeline
DVAXDYNAVAX TECHNOLOGIES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,190,000 shares; 2024Q4: 839,131 shares; 2025Q1: 565,000 shares; 2025Q2: 565,000 shares 565,000$5.6M0.71%0Timeline
PENPENUMBRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,200 shares; 2025Q2: 21,500 shares 21,500$5.52M0.7%+19,300Timeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 116,982 shares; 2024Q4: 195,482 shares; 2025Q1: 126,000 shares; 2025Q2: 99,757 shares 99,757$5.41M0.68%-26,243Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 259,500 shares; 2024Q4: 232,000 shares; 2025Q1: 433,000 shares; 2025Q2: 574,000 shares 574,000$5.38M0.68%+141,000Timeline
BRKRBRUKER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 44,315 shares; 2024Q4: 36,315 shares; 2025Q1: 42,315 shares; 2025Q2: 123,315 shares 123,315$5.08M0.64%+81,000Timeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,290,000 shares; 2025Q2: 1,250,763 shares 1,250,763$4.74M0.6%-39,237Timeline
ASTHASTRANA HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 80,000 shares; 2025Q1: 150,000 shares; 2025Q2: 190,000 shares 190,000$4.73M0.6%+40,000Timeline
UHSUNIVERSAL HLTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,000 shares; 2024Q4: 30,900 shares; 2025Q1: not reported; 2025Q2: 26,000 shares 26,000$4.71M0.6%newTimeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,000 shares; 2024Q4: 22,500 shares; 2025Q1: not reported; 2025Q2: 11,500 shares 11,500$4.55M0.58%newTimeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,100 shares; 2024Q4: 15,640 shares; 2025Q1: 12,640 shares; 2025Q2: 11,140 shares 11,140$4.52M0.57%-1,500Timeline
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 32,000 shares; 2024Q4: 43,500 shares; 2025Q1: 43,500 shares; 2025Q2: 67,250 shares 67,250$4.43M0.56%+23,750Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 55,000 shares 55,000$4.3M0.54%newTimeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 171,500 shares; 2024Q4: 262,500 shares; 2025Q1: 177,500 shares; 2025Q2: 115,000 shares 115,000$4.14M0.52%-62,500Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 90,000 shares; 2024Q4: 72,500 shares; 2025Q1: 52,500 shares; 2025Q2: 52,500 shares 52,500$4.01M0.51%0Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 122,000 shares; 2024Q4: 150,041 shares; 2025Q1: 16,000 shares; 2025Q2: 30,500 shares 30,500$3.96M0.5%+14,500Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 51,000 shares; 2024Q4: 52,750 shares; 2025Q1: 35,750 shares; 2025Q2: 35,870 shares 35,870$3.82M0.48%+120Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 180,500 shares; 2024Q4: 149,250 shares; 2025Q1: 104,250 shares; 2025Q2: 104,250 shares 104,250$3.44M0.44%0Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 82,000 shares; 2025Q2: 93,100 shares 93,100$3.39M0.43%+11,100Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 105,000 shares; 2024Q4: 73,755 shares; 2025Q1: 73,755 shares; 2025Q2: 65,755 shares 65,755$3.35M0.42%-8,000Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 70,000 shares; 2025Q2: 135,100 shares 135,100$2.8M0.35%+65,100Timeline
RDNTRADNET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 46,000 shares 46,000$2.62M0.33%newTimeline
VCELVERICEL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 58,000 shares 58,000$2.47M0.31%newTimeline
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,000 shares; 2024Q4: 9,000 shares; 2025Q1: 4,500 shares; 2025Q2: 19,500 shares 19,500$2.43M0.31%+15,000Timeline
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 53,000 shares 53,000$2.39M0.3%newTimeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 150,000 shares; 2024Q4: 114,000 shares; 2025Q1: 126,627 shares; 2025Q2: 126,627 shares 126,627$2.36M0.3%0Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 102,500 shares; 2024Q4: 90,000 shares; 2025Q1: 100,000 shares; 2025Q2: 85,000 shares 85,000$2.25M0.28%-15,000Timeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 45,000 shares; 2025Q2: 45,000 shares 45,000$2.12M0.27%0Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 300,000 shares; 2024Q4: 290,000 shares; 2025Q1: 249,336 shares; 2025Q2: 185,000 shares 185,000$2.11M0.27%-64,336Timeline
PRVAPRIVIA HEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 95,189 shares; 2024Q4: 121,189 shares; 2025Q1: 98,189 shares; 2025Q2: 91,189 shares 91,189$2.1M0.27%-7,000Timeline
IQVIQVIA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 48,000 shares; 2024Q4: 29,000 shares; 2025Q1: 22,000 shares; 2025Q2: 13,000 shares 13,000$2.05M0.26%-9,000Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 17,000 shares; 2024Q4: 23,750 shares; 2025Q1: 17,750 shares; 2025Q2: 12,750 shares 12,750$1.75M0.22%-5,000Timeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 78,000 shares 78,000$1.66M0.21%newTimeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 367,500 shares; 2024Q4: 195,591 shares; 2025Q1: 28,250 shares; 2025Q2: 93,250 shares 93,250$1.61M0.2%+65,000Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 460,000 shares; 2024Q4: 460,000 shares; 2025Q1: 460,000 shares; 2025Q2: 460,000 shares 460,000$1.59M0.2%0Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 67,100 shares; 2024Q4: 123,700 shares; 2025Q1: 49,500 shares; 2025Q2: 12,000 shares 12,000$1.51M0.19%-37,500Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 166,526 shares; 2024Q4: 314,526 shares; 2025Q1: 195,000 shares; 2025Q2: 250,000 shares 250,000$1.44M0.18%+55,000Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 100,000 shares; 2025Q2: 100,000 shares 100,000$1.4M0.18%0Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 203,750 shares; 2024Q4: 195,750 shares; 2025Q1: 195,750 shares; 2025Q2: 165,750 shares 165,750$1.3M0.16%-30,000Timeline
DOCSDOXIMITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 21,000 shares 21,000$1.29M0.16%newTimeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 106,847 shares; 2024Q4: 170,000 shares; 2025Q1: 141,627 shares; 2025Q2: 55,127 shares 55,127$1.27M0.16%-86,500Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 133,000 shares; 2024Q4: 77,999 shares; 2025Q1: 39,000 shares; 2025Q2: 39,000 shares 39,000$1.12M0.14%0Timeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,052,500 shares; 2024Q4: 1,235,448 shares; 2025Q1: 647,827 shares; 2025Q2: 647,827 shares 647,827$1.11M0.14%0Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 560,000 shares; 2024Q4: 542,500 shares; 2025Q1: 460,000 shares; 2025Q2: 460,000 shares 460,000$1.1M0.14%0Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 35,000 shares; 2024Q4: 35,000 shares; 2025Q1: 35,000 shares; 2025Q2: 35,000 shares 35,000$1.1M0.14%0Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 58,278 shares; 2024Q4: 58,278 shares; 2025Q1: 28,278 shares; 2025Q2: 28,278 shares 28,278$887K0.11%0Timeline
TECHBIO-TECHNE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 20,000 shares; 2024Q4: 3,000 shares; 2025Q1: not reported; 2025Q2: 15,000 shares 15,000$772K0.1%newTimeline
INMBINMUNE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 178,284 shares; 2024Q4: 178,284 shares; 2025Q1: 178,284 shares; 2025Q2: 178,284 shares 178,284$412K0.05%0Timeline

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
BMYBRISTOL-MYERS SQUIBB CO325,000$19.8Mshares
HUMHUMANA INC46,830$12.4Mshares
ZBHZIMMER BIOMET HOLDINGS INC87,250$9.87Mshares
BDXBECTON DICKINSON & CO19,000$4.35Mshares
MRKMERCK & CO INC33,000$2.96Mshares
ESPRESPERION THERAPEUTICS INC NE1,066,495$1.54Mshares
VIRVIR BIOTECHNOLOGY INC200,000$1.3Mshares
ARVNARVINAS INC183,000$1.28Mshares
AMGNAMGEN INC4,000$1.25Mshares
GERNGERON CORP783,000$1.24Mshares
ICLRICON PUB LTD CO7,000$1.22Mshares
MEDPMEDPACE HLDGS INC3,800$1.16Mshares
AVTRAVANTOR INC47,826$775Kshares
IDYAIDEAYA BIOSCIENCES INC39,500$647Kshares
IMVTIMMUNOVANT INC25,924$443Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001213900-25-075249 base2025-08-13acceptance time not in the bulk data set